The vaginal microbiome is gaining traction as an important area of study, reminiscent of the attention previously devoted to the gut microbiome. Recently, individuals have begun to share their experiences with at-home tests designed to analyze the myriad microbes—bacteria, fungi, and others—that inhabit the vagina. Influencers have particularly highlighted these tests as markers of health, prompting many to consider their implications.
Wealthy biohacker Bryan Johnson recently shared that his girlfriend, Kate Tolo, had taken a vaginal microbiome test, ranking her in the “top 1% of all vaginas.” Johnson claimed that this score reflects overall health, emphasizing that it is influenced by lifestyle factors like sleep and diet. Similarly, influencer Kayla Barnes-Lentz boosted her score from 97 to 100, declaring her microbiome to be of “A+” quality.
Despite the buzz, the motives behind these tests often remain unclear. Many individuals are eager to understand what these scores and tests can reveal about health, particularly when they are not experiencing any symptoms. To uncover the truth, I consulted experts in the field and decided to take a test myself.
Choosing a Test
Various brands offer vaginal microbiome tests, typically priced between $150 and several hundred dollars. I opted for Evvy’s test, which focuses on analyzing the vaginal microbiome. According to Priyanka Jain, Evvy’s co-founder and CEO, most users seek insights related to conception difficulties or vaginal symptoms, rather than general health assessments.
Though I wasn’t seeking answers regarding fertility or troublesome symptoms, I noted one concern on the health questionnaire: milky white discharge, which I believed was linked to my menstrual cycle.
The Testing Process
The testing procedure was straightforward. I used a cotton swab to collect cells and fluids from the vaginal wall, then mailed it to the lab. Unlike traditional tests that either culture samples or utilize PCR techniques, these at-home tests employ metagenomic sequencing. This advanced method provides a detailed profile of the bacteria and fungi present.
The results are extensive, presenting a list of identified microbes, from beneficial strains of Lactobacillus to those indicating bacterial vaginosis (BV). Each test generates a “Community State Type,” which classifies the overall microbial community from most to least protective.
Interpreting the Results
Experts agree that the vaginal microbiome is significant, with potential implications for nearby organs like the bladder. However, they caution that understanding what test results mean—especially in the absence of symptoms—is still an evolving science. Presently, there are no guaranteed methods to improve the presence of “good” bacteria.
Dr. Caroline Mitchell, a leading expert in vulvovaginal disorders, noted that while valuable information can be gleaned from the vaginal microbiome, actionable steps based on test results are not always clear-cut. This sentiment was echoed by Dr. Indriati Hood-Pishchany, who highlighted the challenges of translating microbiome data into practical interventions.
In my case, the test results revealed that approximately 60% of my vaginal bacteria belonged to a protective community type and was dominated by Lactobacillus gasseri. However, 11% was attributed to Gardnerella leopoldii, leading to a diagnosis of BV based on my questionnaire response regarding discharge.
The Dilemma of Diagnosis
Interestingly, many women with BV remain asymptomatic. The CDC recommends treatment only for symptomatic individuals. Despite my lack of bothersome symptoms, Evvy provided an extensive treatment plan that included boric acid suppositories, antibiotics, antifungals, and probiotics, totaling around $459.
While I appreciate the importance of addressing health concerns, I find myself hesitant about unnecessary antibiotic use, particularly given the rising issue of antibiotic resistance. The decision to treat should be based on a clear necessity, rather than a test result alone.
The Value of Information
Jain posited that having access to information, even if imperfect, empowers individuals. The current healthcare system often withholds information from women until it is deemed perfect, which Jain argues is unnecessary.
Yet, experts advise that such tests may not be worthwhile for those without symptoms or fertility issues. My experience led me to question whether the diagnosis of BV was relevant to my health, especially as I pondered its potential implications during my pregnancy and my daughter’s premature birth.
Looking Ahead
As I contemplate the possibility of future pregnancies, I wonder if a vaginal microbiome test would provide useful insights. The landscape of microbiome research is still evolving, and while tests may offer intriguing information, the clinical relevance remains to be fully established.
In conclusion, while testing the vaginal microbiome can provide fascinating insights, the implications of those results may not be as straightforward as they seem. Access to information should empower individuals, but careful consideration is essential when interpreting results and determining the need for treatment.
- Key Takeaways:
- The vaginal microbiome is an emerging area of health research.
- At-home tests can provide detailed microbial profiles but may not clarify actionable health steps.
- Many women with conditions like BV are asymptomatic, complicating treatment decisions.
- The importance of context and symptoms should guide the use of microbiome testing.
- Future research may provide clearer insights into the clinical significance of vaginal microbiome results.
Read more → www.health.com